Meyer Handelman Co Has Raised Its Gilead Sciences (GILD) Stake, Matsons (MATX) Shorts Increased By 6.8%

May 30, 2017 - By Darrin Black

Matsons Incorporated (NYSE:MATX) had an increase of 6.8% in short interest. MATX’s SI was 1.31 million shares in May as released by FINRA. Its up 6.8% from 1.23 million shares previously. With 139,600 avg volume, 9 days are for Matsons Incorporated (NYSE:MATX)’s short sellers to cover MATX’s short positions. The SI to Matsons Incorporated’s float is 3.1%. The stock decreased 0.40% or $0.12 on May 26, reaching $30.03. About shares traded. Matson, Inc. (NYSE:MATX) has declined 5.12% since May 30, 2016 and is downtrending. It has underperformed by 21.82% the S&P500.

Meyer Handelman Co increased Gilead Sciences Inc (GILD) stake by 1.31% reported in 2016Q4 SEC filing. Meyer Handelman Co acquired 4,800 shares as Gilead Sciences Inc (GILD)’s stock declined 8.05%. The Meyer Handelman Co holds 371,000 shares with $26.57 million value, up from 366,200 last quarter. Gilead Sciences Inc now has $84.21B valuation. The stock rose 0.47% or $0.3 reaching $64.8 per share. About 958 shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 21.80% since May 30, 2016 and is downtrending. It has underperformed by 38.50% the S&P500.

Among 25 analysts covering Gilead Sciences (NASDAQ:GILD), 16 have Buy rating, 0 Sell and 9 Hold. Therefore 64% are positive. Gilead Sciences had 62 analyst reports since July 29, 2015 according to SRatingsIntel. On Friday, January 15 the stock rating was upgraded by Bank of America to “Neutral”. The company was initiated on Friday, February 5 by Leerink Swann. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Outperform” rating given on Tuesday, October 20 by Oppenheimer. On Wednesday, March 23 the stock rating was maintained by Credit Suisse with “Outperform”. Oppenheimer maintained the stock with “Outperform” rating in Wednesday, February 3 report. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Equal-Weight” rating given on Friday, October 2 by Morgan Stanley. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Strong Buy” rating given on Thursday, September 10 by Jyske Bank. As per Tuesday, November 8, the company rating was initiated by Mizuho. The firm has “Buy” rating by Needham given on Wednesday, July 29. On Tuesday, March 15 the stock rating was maintained by Jefferies with “Hold”.

Investors sentiment decreased to 0.7 in 2016 Q4. Its down 0.23, from 0.93 in 2016Q3. It dived, as 106 investors sold GILD shares while 656 reduced holdings. 111 funds opened positions while 421 raised stakes. 950.84 million shares or 0.69% more from 944.29 million shares in 2016Q3 were reported. Foundry Prtnrs Limited Liability Co holds 0.02% or 7,922 shares. Highlander Capital Ltd holds 400 shares. Gsa Cap Prtnrs Limited Liability Partnership has invested 0.25% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Banque Pictet Cie holds 0.27% in Gilead Sciences, Inc. (NASDAQ:GILD) or 148,479 shares. Ahl Prns Ltd Liability Partnership holds 0.09% or 43,051 shares in its portfolio. Joel Isaacson And Co Ltd Liability Co invested in 522 shares. Cabot holds 146,490 shares. Gotham Asset, New York-based fund reported 1.03M shares. 120,390 were reported by Twin Capital Mngmt. Vident Invest Advisory Ltd Liability has invested 0.24% in Gilead Sciences, Inc. (NASDAQ:GILD). Blackrock Gp Ltd holds 0.48% or 14.22M shares. Wellington Shields Management holds 5,667 shares or 0.07% of its portfolio. Diligent Invsts Lc owns 2,986 shares for 0.17% of their portfolio. Baystate Wealth Management Limited Liability Corp, a Massachusetts-based fund reported 410 shares. Nbt Natl Bank N A New York reported 13,587 shares or 0.17% of all its holdings.

Since December 1, 2016, it had 0 buys, and 9 insider sales for $28.57 million activity. 73,333 shares valued at $5.32 million were sold by MARTIN JOHN C on Wednesday, February 1. On Thursday, March 30 Alton Gregg H sold $337,392 worth of Gilead Sciences, Inc. (NASDAQ:GILD) or 5,000 shares. $1.41 million worth of stock was sold by WILSON GAYLE E on Thursday, February 23. Shares for $668,667 were sold by Cogan John Francis.

Among 3 analysts covering Matson (NYSE:MATX), 0 have Buy rating, 0 Sell and 3 Hold. Therefore 0 are positive. Matson had 4 analyst reports since August 5, 2015 according to SRatingsIntel. The stock of Matson, Inc. (NYSE:MATX) earned “Buy” rating by Stifel Nicolaus on Wednesday, August 5. The stock of Matson, Inc. (NYSE:MATX) has “Neutral” rating given on Thursday, December 15 by Seaport Global. On Tuesday, November 8 the stock rating was downgraded by Stifel Nicolaus to “Hold”. The stock of Matson, Inc. (NYSE:MATX) has “Mkt Perform” rating given on Monday, November 9 by FBR Capital.

Investors sentiment decreased to 1 in Q4 2016. Its down 0.05, from 1.05 in 2016Q3. It dropped, as 15 investors sold Matson, Inc. shares while 59 reduced holdings. 22 funds opened positions while 52 raised stakes. 35.39 million shares or 1.16% more from 34.98 million shares in 2016Q3 were reported. Voya Invest Mgmt Limited Liability Company holds 0% of its portfolio in Matson, Inc. (NYSE:MATX) for 19,149 shares. Northern Tru Corp holds 0.01% or 524,538 shares. Moreover, Hawk Ridge Cap L P has 2.66% invested in Matson, Inc. (NYSE:MATX). Mason Street Advsrs Limited Liability Corp owns 9,361 shares or 0.01% of their US portfolio. Northwestern Mutual Wealth Mngmt, Wisconsin-based fund reported 196 shares. Citigroup, a New York-based fund reported 84,598 shares. Loomis Sayles And Co Limited Partnership stated it has 491 shares. Clearbridge Limited Liability Company stated it has 0.23% of its portfolio in Matson, Inc. (NYSE:MATX). Hsbc Holdings Public Ltd Com holds 9,244 shares. 1,653 were accumulated by Ls Invest Limited Liability Corporation. Blackrock stated it has 0% of its portfolio in Matson, Inc. (NYSE:MATX). West Oak Ltd Liability Company reported 1,000 shares. California Public Employees Retirement Sys has invested 0.01% in Matson, Inc. (NYSE:MATX). Jpmorgan Chase & owns 746,229 shares or 0.01% of their US portfolio. Apriem Advsr reported 300 shares.